378 related articles for article (PubMed ID: 21737886)
21. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
[TBL] [Abstract][Full Text] [Related]
22. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy for gastro-enteropancreatic endocrine tumours.
O'Toole D; Hentic O; Corcos O; Ruszniewski P
Neuroendocrinology; 2004; 80 Suppl 1():79-84. PubMed ID: 15477723
[TBL] [Abstract][Full Text] [Related]
24. The Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future direction.
Furuse J; Ishii H; Okusaka T
Jpn J Clin Oncol; 2013 Jan; 43(1):2-7. PubMed ID: 23100604
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic neuroendocrine tumors: entering a new era.
Oberstein PE; Remotti H; Saif MW; Libutti SK
JOP; 2012 Mar; 13(2):169-73. PubMed ID: 22406593
[TBL] [Abstract][Full Text] [Related]
26. New treatment strategies in advanced neuroendocrine tumours.
Walter T; Brixi-Benmansour H; Lombard-Bohas C; Cadiot G
Dig Liver Dis; 2012 Feb; 44(2):95-105. PubMed ID: 21983252
[TBL] [Abstract][Full Text] [Related]
27. Role of everolimus in pancreatic neuroendocrine tumors.
Goldstein R; Meyer T
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1653-65. PubMed ID: 21932937
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic cancer: updates on translational research and future applications.
Sarris EG; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):145-8. PubMed ID: 23474558
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
Auernhammer CJ; Göke B
Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
[TBL] [Abstract][Full Text] [Related]
30. New tools and novel approaches in treating locally advanced pancreatic adenocarcinoma.
Ahmed WB; Ng J; Wazer DE; Saif MW
JOP; 2012 Jul; 13(4):354-7. PubMed ID: 22797388
[TBL] [Abstract][Full Text] [Related]
31. Locally advanced pancreatic adenocarcinoma: update and progress.
Ng J; Zhang C; Gidea-Addeo D; Saif MW
JOP; 2012 Mar; 13(2):155-8. PubMed ID: 22406589
[TBL] [Abstract][Full Text] [Related]
32. Systemic treatment of advanced pancreatic cancer.
Heinemann V; Haas M; Boeck S
Cancer Treat Rev; 2012 Nov; 38(7):843-53. PubMed ID: 22226241
[TBL] [Abstract][Full Text] [Related]
33. Advances in therapeutic vaccines for pancreatic cancer.
Plate JM
Discov Med; 2012 Aug; 14(75):89-94. PubMed ID: 22935205
[TBL] [Abstract][Full Text] [Related]
34. [Management of localized, locally advanced and metastatic pancreatic adenocarcinoma].
Delpero JR; Turrini O; Raoul JL
Rev Prat; 2015 Mar; 65(3):382-9. PubMed ID: 26016202
[TBL] [Abstract][Full Text] [Related]
35. [Pancreatic adenocarcinoma--a therapeutic challenge].
Korkeila E; Kauhanen S; Mokka M
Duodecim; 2012; 128(18):1851-8. PubMed ID: 23087998
[TBL] [Abstract][Full Text] [Related]
36. Treatment options for advanced pancreatic cancer: a review.
Warsame R; Grothey A
Expert Rev Anticancer Ther; 2012 Oct; 12(10):1327-36. PubMed ID: 23176620
[TBL] [Abstract][Full Text] [Related]
37. [Systemic chemotherapy and chemoradiotherapy for advanced pancreatic cancer].
Ueno H; Okusaka T
Gan To Kagaku Ryoho; 2012 Mar; 39(3):357-63. PubMed ID: 22421761
[TBL] [Abstract][Full Text] [Related]
38. Exocrine Pancreatic carcinoma in Tunisia: A retrospective study about 158 cases.
El Guesmi S; Ben Nasr S; Afrit M; Labidi S; Boussen H
Tunis Med; 2015 Feb; 93(2):73-5. PubMed ID: 26337302
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant therapy for resectable pancreatic adenocarcinoma: review of the current treatment approaches and future directions.
Antoniou G; Kountourakis P; Papadimitriou K; Vassiliou V; Papamichael D
Cancer Treat Rev; 2014 Feb; 40(1):78-85. PubMed ID: 23810287
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic strategies for neuroendocrine liver metastases.
Frilling A; Clift AK
Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
